Cordyceps is a rare fungus long prized in Traditional Chinese Medicine for boosting endurance and oxygen flow. Modern science ...

COSCIENS Biopharma Inc. (NASDAQ: CSCI) (TSX: CSCI) (“COSCIENS” or the “Company”), a life science company which develops and commercializes a diversified portfolio of cosmeceutical, nutraceutical and ...

Omega Laboratories of Ohio, USA, recently announced the development and validation of the Cannabix Marijuana Breath Test; The ...

Stride Expands Across the Midwest, Celebrating its Tenth Center in Iowa and Sixth in Nebraska ...

Cardarine GW501516 is universally recognized as the most effective SARM for cutting and fat loss. Known for its ability to ...

SAN DIEGO, April 01, 2025 (GLOBE NEWSWIRE) -- Cidara Therapeutics, Inc. (Nasdaq: CDTX), a biotechnology company using its proprietary Cloudbreak ® platform to develop drug-Fc conjugate (DFC) ...

Preliminary safety and antitumor activity of zoldonrasib (RMC-9805), an oral, RAS (ON) G12D-selective, tri-complex inhibitor in patients with KRAS G12D non-small cell lung cancer (NSCLC) from a Phase ...

The above-described awards were each granted as an inducement material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635 (c) (4) and were granted ...

BURLINGTON, Mass., April 01, 2025 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will present at the 24th Annual Needham Virtual Healthcare Conference on ...

The foregoing equity award was granted as an inducement material to the employee entering into employment with Cidara, in accordance with Nasdaq Listing Rule 5635 (c) (4). The Inducement Plan is used ...

The Board of Directors approved the grant to Mr. Basta of a non-qualified stock option to purchase 1,085,000 shares of Phathom common stock under the Company’s 2025 Employment Inducement Incentive ...

In addition, Conavi Medical reports that an ordinary resolution approving the appointment of PricewaterhouseCoopers LLP as the Company’s auditors for the ensuing year and to authorize the directors to ...